Adriamycin increases podocyte permeability: Evidence and molecular mechanism

Chinese Medical Journal

Volumn 116, Issue 12, 2003, Pages 1831-1835

  Li, Xiaozhong ^a   Yuan, Haitao ^b   Zhang, Xueguang ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adriamycin; Dexamethasone; P cadherin; Permeability; Podocytes; ZO 1

Indexed keywords

ALBUMIN; CADHERIN; DEXAMETHASONE; DOXORUBICIN; PROTEIN ZO1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DISRUPTION; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; IMMUNOCYTOCHEMISTRY; MINIMAL CHANGE GLOMERULONEPHRITIS; MOLECULAR MECHANICS; MONOLAYER CULTURE; MOUSE; NONHUMAN; PODOCYTE; PROTEINURIA; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING;

ALBUMINS; ANIMALS; CADHERINS; CELL MEMBRANE PERMEABILITY; CELLS, CULTURED; DEXAMETHASONE; DOXORUBICIN; EPITHELIAL CELLS; KIDNEY GLOMERULUS; MICE;

EID: 0742324060     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Smoyer WE, Mundel P. Regulation of podocyte structure during the development of nephrotic syndrome. Mol Med 1998;76:172-183.
2. Pavenstadt H. Roles of the podocyte in glomerular function. Am J Physiol Renal Physiol 2000;278:F173-179.
3. Kriz W, Gretz N, Lemley KV. Progression of glomerular diseases: is the podocyte the culprit? Kidney Int 1998;54: 687-697.
4. Corey HE, Spitzer A. Renal blood flow and glomerular filtration rate during development. In Paediatric Kidney Disease (Vol I). 2nd ed. Boston: Little Brown; 1992:49-67.
5. Luimula P, Ahola H, Wang SX, et al. Nephrin in experiment glomerular disease. Kidney Int 2000;58:1461-1468.
6. Ruotsalainen V, Patrakka J, Tissari P, et al. Role of nephrin in cell junction formation in human nephrogenesis. Am J Pathol 2000;157:1905-1916.
7. Deschenes G, Martinat L. Molecular basis of idiopathic nephritic syndrome (French). Arch Pediatr 2000;7:1318-1329.
8. Macconi D, Ghilardi M, Bonassi ME, et al. Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol 2000;11:477-489.
9. Kawachi H, Kurihara H, Topham PS, et al. Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol 1997;273:F984-F9993.
10. Jalanko H, Patrakka J, Tryggvason K, et al. Genetic kidney diseases disclose the pathogenesis of proteinuria. Ann Med 2001;33:526-533.
11. Reiser J, Kriz W, Kretzler M, et al. The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol 2000;11:1-8.
12. Inoue T, Yaoita E, Kurihara H, et al. FAT is a component of glomerular slit diaphragms. Kidney Int 2001;59:1003-1012.
13. Bertani T, Poggi A, Pozzoni R, et al. AD-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 1982;46:16-23.
14. Okasora T, Takikawa T, Utsunomiya Y, et al. Suppressive effect of superoxide dismutase on AD nephropathy. Nephron 1992;60:199-203.
15. Ghiggeri GM, Ginevri F, Cercignani G, et al. Effect of dietary protein restriction on renal purines and purine-metabolizing enzymes in AD nephrosis in rats: a mechanism for protection against acute proteinuria involving xanthine oxidase inhibition. Clin Sci 1990;79:647-656.
16. Zima T, Tesar V, Crkovska J, et al. ICRF-187 (dexrazoxan) protects from AD-induced nephrotic syndrome in rats. Nephrol Dial Transplant 1998;13:1975-1979.
17. Yan K, Kudo A, Hirano H, et al. Subcellular localization of glucocorticoid receptor protein in the human kidney glomerulus. Kidney Int 1999;56:65-73.
18. Mundel P, Krill W. Structure and function of podocytes: an update. Anat Embryol 1995;192:385-97.
19. Remuzzi G, Zoja C, Remuzzi A, et al. Low-protein diet prevents glomerular damage in AD-treated rats. Kidney Int 1985;28:21-27.
20. Chen A, Wei CH, Sheu LF, et al. Induction of proteinuria by AD or bovine sreum albumin in the mouse. Nephron 1995; 69:293-300.